10 June 2022 | News
Collaborates with its French counterpart to manufacture the new technology indigenously in India
Pharma player Gufic Biosciences has targeted to capture a major share of Rs 3000-crore lyophilised antibiotics antifungal market in India. The company has launched New Drug Delivery System: Dual Chamber Bags at an affordable price first time in India.
Gufic Biosciences has collaborated with its French counterpart to manufacture this new technology indigenously in India. The dual-chamber bags launched by Gufic Biosciences are 2-Chamber IV Bags made up of polypropylene (DEHP free) with a peelable aluminium foil allowing the storage of unstable drugs which need a reconstitution just before the administration to the patient. The peelable seal separates lyophilised (or powder) drugs and the diluent. Moreover, the product complies with the US and EU pharmacopoeias and it is manufactured in ISO7 clean room under cGMP.